| ［1］ |
Fujita H, Terui T, Hayama K, et al. Japanese guidelines for the management and treatment of generalized pustular psoriasis: the new pathogenesis and treatment of GPP［J］. J Dermatol, 2018,45（11）:1235⁃1270. doi: 10.1111/1346⁃8138.14523.
|
| ［2］ |
Trivedi MK, Vaughn AR, Murase JE. Pustular psoriasis of pregnancy: current perspectives［J］. Int J Womens Health, 2018,10:109⁃115. doi: 10.2147/IJWH.S125784.
|
| ［3］ |
Li XN, Peng B, Geng SM. Characterization of generalized pustular psoriasis in Northwest China: a single⁃center retrospective study［J］. Int J Dermatol Venerol, 2022,5（4）:191⁃198. doi: 10.1097/JD9.0000000000000275.
|
| ［4］ |
Yoshikawa M, Rokunohe D, Kimura A, et al. Significance of IL36RN mutation analyses in the management of impetigo herpetiformis: a case report and review of published cases［J］. J Dermatol, 2021,48（5）:699⁃702. doi: 10.1111/1346⁃8138.15788.
|
| ［5］ |
Babuna Kobaner G, Polat Ekinci A. Infliximab for the treatment of recalcitrant generalized pustular psoriasis of pregnancy: report of a challenging case［J］. Dermatol Ther, 2020,33（4）:e13571. doi: 10.1111/dth.13571.
|
| ［6］ |
Adachi A, Komine M, Hirano T, et al. Case of generalized pustular psoriasis exacerbated during pregnancy, successfully treated with infliximab［J］. J Dermatol, 2016,43（12）:1439⁃1440. doi: 10.1111/1346⁃8138.13429.
|
| ［7］ |
中华医学会皮肤性病学分会, 中国医师协会皮肤科医师分会, 中国中西医结合学会皮肤性病专业委员会. 中国银屑病生物制剂治疗指南（2021）［J］. 中华皮肤科杂志, 2021,54（12）:1033⁃1047. doi: 10.35541/cjd.20210643.
|
| ［8］ |
Liu N, Zhu L, Cheng Y, et al. Successful treatment of recurrent pustular psoriasis of pregnancy with secukinumab: a case report［J］. Acta Derm Venereol, 2020,100（15）:adv00251. doi: 10.2340/00015555⁃3611.
|
